THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF STROKES: A PROGRESS REPORT
Authors: IRVING S. WRIGHT
Journal: Annals of Internal Medicine (1958)

Article1 November 1958THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF STROKES: A PROGRESS REPORTIRVING S. WRIGHT, M.D., F.A.C.P.IRVING S. WRIGHT, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-49-5-1004 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFour years ago I presented before the Annual Session of the College a brief analysis of the state of knowledge concerning certain major aspects of the problem of strokes.1Emphasis was placed on the need for greater interest in this field, which is so important individually, numerically (approximately 2,000,000 persons living today have had strokes, and about 200,000 die each year from this cause), and economically. While major problems in this area remain unsolved, it is with pleasure that we can now recount signs of substantial progress. There has been a great increase in interest on the part of investigators...Bibliography1. WrightMcDevitt ISE: Cerebral vascular diseases: significance, diagnosis and present treatment, including selective use of anticoagulant substances, Ann. Int. Med. 41: 682 (Oct.) 1954. LinkGoogle Scholar2. WrightLuckey ISEH(a) : Cerebral vascular diseases, Transactions of Conference, Princeton, New Jersey, January 1954, 1955, Grune & Stratton, Inc., New York. (b) Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc., New York. Google Scholar3. Adams R: The nomenclature of cerebrovascular diseases, Neurology, in press. Google Scholar4. Bronte-StuartKeysBronk BAJF: Serum cholesterol, diet and coronary heart disease: an inter-racial survey in Cape Peninsula, Lancet 2: 1103, 1955. CrossrefGoogle Scholar5. Bronte-StuartAntonisEalesBrock BALJF: Effects of feeding different fats on serum cholesterol levels, Lancet 1: 521, 1956. CrossrefGoogle Scholar6. KeysAndersonAresuBjorkBrockBronte-StuartFidanzaKeysMalmrosPoppiPosteliSwahnDel Vecchio AJTMGJFBFMHHATBA: Physical activity and the diet in populations differing in serum cholesterol, J. Clin. Investigation 35: 1173, 1956. CrossrefMedlineGoogle Scholar7. AhrensDoleBlankenhorn EHVPDH(a) : The use of orally fed liquid formulas in metabolic studies, Am. J. Clin. Nutrition 2: 336, 1954. (b) Ahrens, E. H., Jr., Hirsch, J., Insull, W., Jr., Tsaltas, T. T., Blomstrand, R., and Peterson, M. L.: Dietary control of serum lipids in relation to atherosclerosis, J. A. M. A. 164: 1905, 1956. (c) Ahrens, E. H., Jr., Insull, W., Blomstrand, R., Hirsch, J., Tsaltas, T. T., and Peterson, M. L.: The influence of dietary fats on serum lipid livels in man, Lancet 1: 843, 1957. (d) Ahrens, E. H., Jr.: Dietary fats and human lipid levels, in Chemistry of lipids as related to atherosclerosis, edited by Page, I. H., 1958, Charles C Thomas, Springfield, Illinois. CrossrefMedlineGoogle Scholar8. MalmrosWigand HG(a) : Treatment of hypercholesterolemia, Minnesota Med. 38: 863, 1955. (b) Malmros, H., and Wigand, G.: The effect upon serum cholesterol of diets containing different fats, Lancet 3: 1, 1957. Google Scholar9. PerkinsWrightGatje RISBW: Effect of safflower oil emulsion on serum cholesterol levels in young adult males: its use as a supplement to a normal diet, J. A. M. A., in press. Google Scholar10. YerushalmyHilleboe JHE: Fat in the diet and mortality from heart disease, New York State J. Med. 57: 2343 (July 15) 1957. MedlineGoogle Scholar11. Stamler J: Atherosclerosis: evaluation of therapy: hormones, vegetable oils, low cholesterol diet, sitosterols, in Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc., New York. Google Scholar12. DawberMeadorsMoore TRGFFE(a) : Epidemiological approach to heart disease: Framingham Study, Am. J. Pub. Health 41: 279-286, 1951. (b) Stokes, J., III, and Dawber, T. R.: Rheumatic heart disease in the Framingham Study, New England J. Med. 255: 1228-1233 (Dec. 27) 1956. CrossrefGoogle Scholar13. Kusakawa A: Statistical findings on the incidence of coronary heart disease in Japan, Vol. I, Cardiovascular epidemiology, edited by Keys, A., and White, P. D., 1956, Hoeber-Harper, New York, p. 161. Google Scholar14. Becker BJ: Cardio-vascular disease in Bantu and colored races of South Africa; atheromatosis, South African J. M. Sc. 11: 97-105 (Nov.) 1946. MedlineGoogle Scholar15. Edrington GM: Cardiovascular disease as a cause of death in the Gold Coast African, Tr. Roy. Soc. Trop. Med. and Hyg. 48: 419-425 (Sept.) 1954. CrossrefMedlineGoogle Scholar16. LaurieWoods WJD: Atherosclerosis and its cerebral complications in the South African Bantu, Lancet 1: 231 (Feb. 1) 1958. CrossrefMedlineGoogle Scholar17. Wilson SA: Neurology, 2nd Ed., Vol. 3, Part VII, edited by Bruce, A. N., 1954-55, Butterworth & Co., London. Google Scholar18. RussEderBarr EMHADP(a) : Influence of gonadal hormones on protein-lipid relationships in human plasma, Am. J. Med. 19: 4-24 (July) 1955. (b) Barr, D. P.: The pathogenesis of atherosclerosis, Annual Lecture, Cleveland Academy of Medicine, May 18, 1951. CrossrefMedlineGoogle Scholar19. MarmorstonMagidsonSobelLewisBersteinMooreKuzmaAlexander JOHJJFJOR(a) : Steroid hormone excretion after myocardial infarction. The lipoproteins, Symposia on Research Advances Applied to Medical Practice, No. 3, 1957, S. Karger, Basel, Switzerland. (b) Marmorston, J., Lewis, J. J., Bernstein, J. L., Sobel, H., Kuzma, O., Alexander, R., Magidson, Q., and Moore, F. J.: Excretion of urinary steroids by men and women with myocardial infarction, Geriatrics 12: 297, 1957. Google Scholar20. Myasnikov AL: Influence of some factors on development of experimental cholesterol atherosclerosis, Circulation 17: 99 (Jan.) 1958. CrossrefMedlineGoogle Scholar21. Wright IS: The pathogenesis, prevention and medical management of peripheral arterial thrombosis, Am. J. Med. 23: 704 (Nov.) 1957. CrossrefMedlineGoogle Scholar22. Edsall JT: Some unsolved problems in the chemistry of the blood, Transactions of the First Conference on Blood Clotting, 1948-1949, Josiah Macy, Jr. Foundation, New York. Google Scholar23. Ferry JD: Consideration of the structure and mechanism of formation of the fibrin clot, Transactions of the Second Conference on Blood Clotting, 1949, Josiah Macy, Jr. Foundation, New York, p. 84. Google Scholar24. HoranHirschWoodWright FEFGLAIS: Surface effects on blood-clotting components as determined by zeta-potentials, J. Clin. Investigation 24: 202, 1950. CrossrefGoogle Scholar25. WoodHoranSheppardWright LAFEEIS: Zeta-potential measurements as a tool for studying certain aspects of blood coagulation, Transactions of the Third Conference on Blood Clotting, 1950, Josiah Macy, Jr. Foundation, New York. Google Scholar26. SheppardWright EIS: Electrokinetic studies on fibrinogen. III. The effect of concentration, pH and surface on the fibrinogen-solid interfacial potential, Arch. Biochem. and Biophys. 52: 414, 1954. CrossrefMedlineGoogle Scholar27. SheppardWright EIS: Electrokinetic studies on fibrinogen-solid interfacial potential, Arch. Biochem. and Biophys. 52: 426, 1954. CrossrefMedlineGoogle Scholar28. SheppardImperanteWright EJIS: The action of heparin on the polymerization of fibrinogen, J. Phys. Chem. 60: 584, 1956. CrossrefGoogle Scholar29. Owren PA: The present state of the converting and accelerator factors in prothrombin conversion. I. International Conference on Thrombosis and Embolism, 1954 and 1955, Benno Schwabe & Co., Basel, p. 65. Google Scholar30. Hayem G: Sur le méchanisme de l'ârret des hemorrhagies, Compt. rend. Acad. d. sc. 95: 18, 1882. Google Scholar31. Bizzozero J: Ueber einen neuen Formbestandtheil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung, Virchows Arch. f. path. Anat. 90: 261, 1882. CrossrefGoogle Scholar32. Apitz K: Die Bedeutung des Gerinnung und Thrombose für die Blutstillung, Virchows Arch. f. path. Anat. 308: 540, 1942. CrossrefGoogle Scholar33. Zucker MB: Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal thrombocytopenic, heparinized and hypoprothrombinemic rats, Am. J. Physiol. 148: 275, 1947. CrossrefMedlineGoogle Scholar34. Zucker HD: Platelet thrombosis in human hemostasis; a histologic study of skin wounds in normal and purpuric individuals, Blood 4: 631, 1949. CrossrefMedlineGoogle Scholar35. Wright HP: The role of platelets, Transactions of the Fourth Conference on Blood Clotting, 1951, Josiah Macy, Jr. Foundation, New York. Google Scholar36. DuncanWaldron GGJM: The effect of ingested fat on blood coagulation, Tr. A. Am. Physicians 42: 179, 1949. Google Scholar37. TullochOvermanWright JRSIS: Failure of ingestion of cream to affect blood coagulation, Am. J. Med. 14: 674, 1953. CrossrefMedlineGoogle Scholar38. WaldronDuncan JMGG: Variability of the rate of coagulation of whole blood, Am. J. Med. 17: 365, 1954. CrossrefMedlineGoogle Scholar39. BuzinaKeys RA: Blood coagulation after a fat meal, Circulation 14: 854, 1956. CrossrefMedlineGoogle Scholar40. BorreroSheppardWright JEIS: Further experiences with blood coagulation after fat meals and carbohydrate meals, Circulation, in press. Google Scholar41. O'Brien JR: Effect of a meal of eggs and different fats on blood coagulability, Lancet 2: 232, 1956. CrossrefGoogle Scholar42. SheehyEichelberger TWJW: Alimentary lipemia and the coagulability of blood. Analysis by thrombelastography and silicone clotting time, Circulation, in press. Google Scholar43. BlumgartFreedbergZollLewisWessler HLASPMHDS: The effect of Dicumarol on the heart in experimental acute coronary occlusion, Tr. A. Am. Physicians 60: 228, 1947. Google Scholar44. FrazierHillWakimSayreMillikanWhisnant SHNCKGGPCHJP: Influence of anticoagulants on cerebral infarction produced by homologous blood clots, Proc. Staff Meet., Mayo Clin. 32: 717-722 (Dec. 11) 1957. MedlineGoogle Scholar45. SibleyMorledgeLapham WAJHLW: Experimental cerebral infarction: the effect of Dicumarol, Am. J. M. Sc. 234: 663-677 (Dec.) 1957. CrossrefMedlineGoogle Scholar46. MillikanSiekertSchick CHRCRM(a) : Studies in cerebrovascular disease. III. Use of anticoagulant drugs in treatment of insufficiency or thrombosis within basilar arterial system, Proc. Staff. Meet., Mayo Clin. 30: 116 (Mar. 23) 1955. (b) Millikan, C. H., Siekert, R. C., and Schick, R. M.: Studies in cerebrovascular disease. V. Use of anticoagulant drugs in treatment of intermittent insufficiency of internal carotid arterial system, Proc. Staff Meet., Mayo Clin. 30: 578 (Nov. 30) 1955. (c) Millikan, C. H., Siekert, R. G., and Whisnant, J.: Anticoagulant therapy in cerebral vascular disease; current status, J. A. M. A. 166: 587 (Feb. 8) 1958. MedlineGoogle Scholar47. McDevittCarterGatjeFoleyWright ESABWWTIS: Use of anticoagulants in the treatment of cerebral vascular disease; ten year experience in the treatment of thromboembolism, J. A. M. A. 166: 592 (Feb. 8) 1958. CrossrefMedlineGoogle Scholar48. Fisher M(a) : Comments, in Wright, I. S., chairman, and Luckey, E. H., Editor: Cerebral vascular diseases, Transactions of the Conf., Princeton, New Jersey, January 24-26, 1954, 1955, Grune & Stratton, Inc., New York, p. 39. (b) Fisher, M.: Intermittent cerebral ischemia; basilar and carotid artery disease; the slow stroke; the recurrent stroke, in Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of the Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc., New York. Google Scholar49. Adams R(a) : Pathology of cerebral vascular diseases, in Wright, I. S., and Luckey, E. H.: Cerebral vascular disease, Transactions of the Conference, Princeton, New Jersey, January 24-26, 1954, 1955, Grune & Stratton, Inc., New York, p. 25. (b) Adams, R.: The time table of pathological changes in cerebral infarction and the differential diagnosis of thrombosis, hemorrhage, embolism, in Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of the Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc., New York. Google Scholar50. NylinKety GS: Cerebral blood flow: estimated with thorium B-labelled erythrocytes and other methods, in Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of the Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc., New York. Google Scholar51. Oliverona H(a) : Surgical treatment of the arteriovenous aneurysms and vascular tumors of the brain, Fifth International Neurological Congress, 1953, p. 145. (b) Oliverona, H., and Riives, J.: Arteriovenous aneurysms of the brain: their diagnosis and treatment, Arch. Neurol. and Psychiat. 59: 567, 1948. Google Scholar52. SvienHooker HJJP: The case against carotid ligature in the neck in the treatment of arteriovenous anomalies of the cerebrum, Proc. Staff Meet., Mayo Clin. 32: 739 (Dec. 25) 1957. MedlineGoogle Scholar53. DeBakeyMorrisJordanCooley MEGCGLDA: Segmental thrombo-obliterative disease of branches of aortic arch: successful surgical treatment, J. A. M. A. 166: 998 (Mar. 1) 1958. CrossrefMedlineGoogle Scholar54. LyonsGalbraith CG: Surgical treatment of arteriosclerotic occlusion of the internal carotid artery, Tr. Am. S. A. 75: 183, 1957. Google Scholar55. CooleyAl-NaamanCorton DAYDCA: Surgical treatment of arteriosclerotic occlusion of common carotid artery, J. Neurosurg. 13: 500, 1956. CrossrefMedlineGoogle Scholar56. BotterellGurdjianBucy HEP: Surgical aspects of aneurysm: hemorrhage and thrombosis: hypothermia, in Wright, I. S., and Millikan, C. H.: Cerebral vascular diseases, Transactions of the Second Conference, Princeton, New Jersey, January, 1957, Grune & Stratton, Inc. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Presented as a Morning Lecture at the Thirty-ninth Annual Session of The American College of Physicians, Atlantic City, New Jersey, April 29, 1958.From the Vascular Section of the Department of Medicine of the New York Hospital-Cornell University Medical College.†Aided by grants from the National Institutes of Health and the Lasker, Hyde, Hampil and Fullerton Foundations.Requests for reprints should be addressed to Irving S. Wright, M.D., The New York Hospital, 525 East Sixty-eighth Street, New York 21, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByStroke-Past, Present and Future: A Personal ViewOcclusive cerebrovascular diseaseTreatment of a Stroke 1 November 1958Volume 49, Issue 5Page: 1004-1021KeywordsAnticoagulantsAtherosclerosisHemorrhageHypertensionPathogenesisProteinsStrokeThrombosisVascular medicine Issue Published: 1 November 1958 PDF DownloadLoading ...